Rimar Capital USA, Inc., Rimar Capital, LLC, Itai Royi Liptz, and Clifford Todd Boro
Rimar Capital USA, Inc., Rimar Capital, LLC, Itai Royi Liptz, and Clifford Todd Boro
Synchronoss Technologies, Inc., Clayton “Charlie” Thomas, Marc Bandini, Daniel Ives, John Murdock, Ronald Prague, Esq.
Synchronoss Technologies, Inc., Clayton “Charlie” Thomas, Marc Bandini, Daniel Ives, John Murdock, Ronald Prague, Esq.
Navigating the New Antipsychotic Quality Measure: Compliance, Coding, and Five-Star Impact
The January 2026 CMS revisions to the Long-Stay Antipsychotic Quality Measure—now incorporating Medicare Fee-for-Service, Medicaid, and Medicare Advantage claims—create a more expansive and sensitive methodology that can trigger the measure even when antipsychotics were not administered during the MDS look-back period. This shift, combined with CMS concerns around underreporting and inaccurate diagnosis coding, places heightened pressure...
See You at the LeadingAge Iowa Annual Conference!
Pathway Health will be attending the LeadingAge Iowa Annual Conference on May 6-7. This year’s conference theme, Changemakers, celebrates the bold spirit that drives our field forward, and our team members are very excited to connect with fellow leaders and learn throughout the different educational sessions. We invite you to learn more about Pathway Health’s...
